Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

70.02
-1.4400-2.02%
Volume:184.42K
Turnover:13.05M
Market Cap:1.61B
PE:15.42
High:71.92
Open:71.53
Low:70.00
Close:71.46
52wk High:99.39
52wk Low:69.96
Shares:22.97M
Float Shares:20.28M
Volume Ratio:0.73
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.69
PE(LYR):21.09

Loading ...

ANI Pharmaceuticals director Thomas Haughey disposes of 2,000 shares for $161,760

Reuters
·
Jun 11

ANI Pharma SVP, CFO Stephen P. Carey disposes of 3,312 common shares for $264,960

Reuters
·
Jun 10

A Look At ANI Pharmaceuticals (ANIP) Valuation As Shares Trade Below Popular Fair Value Estimate

Simply Wall St.
·
Jun 03

ANI Pharmaceuticals Signals Confident 2026 Growth Path

TIPRANKS
·
Jun 02

ANI Pharma CEO Lalwani to speak at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 27

ANI Pharmaceuticals shareholders approve amended 2022 stock incentive plan at annual meeting

Reuters
·
May 22

ANI Pharmaceuticals (ANIP) Gets a Buy from Barclays

TIPRANKS
·
May 20

Emmaus Life Sciences Q1 FY26 net loss widens to $3.3 million; net revenues fall 18% to $2 million

Reuters
·
May 16

Top Executives Quietly Unload a Wave of ANI Pharmaceuticals Shares

TIPRANKS
·
May 14

ANI Pharma director Patrick D. Walsh disposes common shares worth $1.13 million

Reuters
·
May 14

ANI Pharma CEO Nikhil Lalwani sells 55,000 shares for $4.27 million

Reuters
·
May 14

ANI SVP Thomas Rowland disposes 459 shares for $36,357.39

Reuters
·
May 14

ANI Pharma General Counsel Meredith Cook sells 500 shares worth $39,080

Reuters
·
May 14

ANI Pharma releases corporate presentation outlining rare-disease shift, 2026 revenue outlook $1.1-$1.14 billion

Reuters
·
May 13

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Definitive Healthcare Corp (DH) and Denali Therapeutics (DNLI)

TIPRANKS
·
May 11

Guggenheim Sticks to Its Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
May 11

U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla

Reuters
·
May 11

ANI Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $105 From $111

THOMSON REUTERS
·
May 11

ANI Pharmaceuticals (ANIP) Profit Swing And One Off Gain Test Bullish Narratives

Simply Wall St.
·
May 09

H.C. Wainwright Sticks to Their Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
May 09